Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells

被引:16
作者
Cao, YZ
Cohen, ZS
Weaver, JA
Sordillo, LM [1 ]
机构
[1] Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA
[2] Penn State Univ, Grad Program Physiol, University Pk, PA 16802 USA
关键词
D O I
10.1089/152308601317203657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selenium (Se) deficiency has been reported to increase platelet-activating factor (PAF) production in human endothelial cells; however, the mechanism is unclear. This study demonstrated that tumor necrosis factor-alpha (TNF-alpha) stimulated Se-deficient bovine aortic endothelial cells (BAEC) produced significantly more PAF than Se-supplemented cells. Moreover, the increase in the level of PAF was associated with enhanced activity of two anabolic enzymes in the remodeling pathway: phospholipase A(2) and Lyso-PAF:acetyl-coenzyme A acetyltransferase (Lyso-PAF-AcT). In contrast, the activity of the PAF catabolic enzyme, PAF-acetylhydrolase, was not affected by Se status. Interestingly, prostacyclin, a potent vasodilator and inhibitor of platelet aggregation, inhibited the activity of Lyso-PAF-AcT and reduced the PAF production in TNF-alpha-stimulated BAEC. Therefore, we conclude that Se deficiency alters PAF production in TNF-alpha-stimulated BAEC by altering the activity of anabolic enzymes involved in the remodeling pathway partially through the inhibition of prostacyclin production.
引用
收藏
页码:1147 / 1152
页数:6
相关论文
共 20 条
[11]   ACTIVATION OF PHOSPHOLIPASE A(2) AND ACYLATION OF LYSOPHOSPHOLIPIDS - THE MAJOR REGULATORS FOR PLATELET-ACTIVATING-FACTOR PRODUCTION IN RAT NEUTROPHILS [J].
NARABA, H ;
IMAI, Y ;
KUDO, I ;
NAKAGAWA, Y ;
OHISHI, S .
JOURNAL OF BIOCHEMISTRY, 1995, 118 (02) :442-447
[12]  
PINCKARD RN, 1979, J IMMUNOL, V123, P1847
[13]   PLATELET-ACTIVATING-FACTOR IN BRONCHOALVEOLAR LAVAGE FROM PATIENTS WITH SARCOIDOSIS [J].
SCAPPATICCI, E ;
LIBERTUCCI, D ;
BOTTOMICCA, F ;
DACOL, R ;
SILVESTRO, L ;
TETTA, C ;
CAMUSSI, G .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02) :433-438
[14]   PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES [J].
SNYDER, F .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1254 (03) :231-249
[15]  
Sordillo L. M., 1998, Methods in Cell Science, V19, P243, DOI 10.1023/A:1009759132250
[16]  
Vitoux D, 1996, ANN BIOL CLIN-PARIS, V54, P181
[17]   Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells [J].
Weaver, JA ;
Maddox, JF ;
Cao, YZ ;
Mullarky, IK ;
Sordillo, LM .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 30 (03) :299-308
[18]   CYTOLYTIC AND MEMBRANE-PERTURBING PROPERTIES OF LYSOPHOSPHATIDYLCHOLINE [J].
WELTZIEN, HU .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 559 (02) :259-287
[19]  
Yang Guang-Qi, 1995, Biomedical and Environmental Sciences, V8, P187
[20]   PRODUCTION OF PLATELET-ACTIVATING FACTOR BY HUMAN VASCULAR ENDOTHELIAL-CELLS - EVIDENCE FOR A REQUIREMENT FOR SPECIFIC AGONISTS AND MODULATION BY PROSTACYCLIN [J].
ZIMMERMAN, GA ;
MCINTYRE, TM ;
PRESCOTT, SM .
CIRCULATION, 1985, 72 (04) :718-727